摘要
Background: Pre- and post-treatment plasma Epstein-Barr virus (EBV) DNA are important biomarkers for the prognosis of nasopharyngeal carcinoma (NPC). This study was performed to determine the prognostic potential of integrating EBV DNA levels in plasma measured pre-treatment (pre-EBV) and 3 months post-treatment (3 m-EBV). @@@ Materials and methods: A total of 543 incident non-metastatic NPC patients treated with intensity-modulated radiotherapy, with or without chemotherapy, were reviewed. Patients were divided into four subgroups based on pre-EBV and 3 m-EBV status. The data for pre-EBV and 3 m-EBV samples were integrated, and the predictability of the survival of patients with NPC was analyzed. @@@ Results: There were significant differences in the 5-year progression-free survival, distant metastasis-free survival, locoregional relapse-free survival, and overall survival among the four patient subgroups (P<0.001). Patients who tested negative for both pre-EBV and 3 m-EBV had the best prognosis, followed by patients who tested positive for pre-EBV and negative for 3 m-EBV, and those who tested negative for pre-EBV and positive for 3 m-EBV; however, patients who tested positive for both pre-EBV and 3 m-EBV had the poorest chances of survival. Multivariate analyses demonstrated that integration of pre-EBV and 3 m-EBV data was an independent predictor of NPC progression in patients. Receiver operating characteristic curve analysis further confirmed that the combination of pre-EBV and 3 m-EBV had a greater prognostic value than pre-EBV or 3 m-EBV alone. @@@ Conclusions: Integrating pre-EBV and 3 m-EBV data could provide more accurate risk stratification and better prognostic prediction in NPC.
学科与关键词
- Long-term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinomaLi, Wanxia; Chen, Jing; Liang, Bijun; Li, Zonghua; Li, Junzheng; Yuan, Xiaofei; Wu, Shuting; Zeng, Fangfang; Peng, Xinyu; Li, Yanfei; Lu, Juan*; Zhao, Feipeng*; Liu, Xiong*Cancer Medicine, 2021, 10(3): 883-894.被引 12
- An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein-Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysisLi, Jun Yan; Huang, Cheng Long; Luo, Wei Jie; Zhang, Yuan; Tang, Ling Long; Peng, Hao; Sun, Ying; Chen, Yu Pei*; Ma, Jun*Therapeutic Advances in Medical Oncology, 2019, 11: UNSP 1758835919877729.
- Combination of smoking and Epstein-Barr virus DNA is a predictor of poor prognosis for nasopharyngeal carcinoma: a long-term follow-up retrospective studyLi, Wanxia; Yang, Chao; Zhao, Feipeng; Li, Junzheng; Li, Zonghua; Ouyang, Ping; Yuan, Xiaofei; Wu, Shuting; Yuan, Yue; Cui, Linchong; Feng, Huiru; Lin, Danfan; Chen, Zilu; Lu, Juan*; Peng, Xiaohong*; Chen, Jing*BMC CANCER, 2022, 22(1): 1262.被引 2
